News

26 September 2022

Navigo and Mannin Sign Agreement to Develop Innovative Affinity Ligand Against a Novel Drug for the Treatment of COVID-19

Navigo Proteins Successfully Develops Affinity Resin against Ferritin for blood fraction processing

Navigo Proteins Announces Launch of an Exclusive Affinity Resin for the Capture of gp64

9 September 2021

Repligen and Navigo GmbH Announce Launch of Industry-First Protein A Ligand for Purification of pH Sensitive Antibodies

Navigo Proteins and Eleva Announce Successful Development of an Affinity Chromatography Resin Customized for the Efficient Purification of Human Complement-Factor H

8 February 2021

Repligen and Navigo Proteins Announce the Launch of an Affinity Resin for the Purification of COVID-19 Vaccines